NasdaqGS:CLOVHealthcare
Clover Health Investments (CLOV) Could Be 11% Undervalued On Raised 2026 Guidance
Clover Health Investments earnings shift draws investor focus
Clover Health Investments (CLOV) is back on investor radars after reporting a second quarter net income of US$28 million, compared with a net loss a year earlier, and issuing higher full year 2026 revenue and profit guidance.
See our latest analysis for Clover Health Investments.
Clover Health Investments’ latest results and raised 2026 guidance have come alongside a strong shift in sentiment, with a 90.87% year to date share price...